USFDA begins inspections of Indian manufacturing sites deemed mission-critical

Inspections of sites deemed to be mission critical for the US resumed last month. The American drug regulator’s India director Christopher Middendorf also said that the USFDA may grant approval without inspection if a drug belongs to an already approved profile and the manufacturer has a solid Good Manufacturing Practices record

from Moneycontrol Business News https://ift.tt/3bH0CFP